Pioneering Research. Elevating Science.
High quality, scientifically formulated peptides
Featured Products
This peptide combination is being investigated in laboratory settings for its interaction with receptor-mediated signaling pathways.
For research use only. Not for human or animal consumption.
🧬 OVERVIEW
CJC-1295 (without DAC) and Ipamorelin are synthetic peptides studied for their interaction with receptor pathways in controlled laboratory environments. Research has examined their binding characteristics and downstream signaling responses in preclinical models.
⚗️ RESEARCH APPLICATIONS
Receptor binding affinity studies
Signal cascade analysis
Hormone pathway modeling (laboratory only)
Peptide synergy interaction research
⚠️ DISCLAIMER BLOCK
This product is strictly for laboratory research purposes.
Not for ingestion or injection
Not for medical use
Not for human or veterinary applications
Product Overview
Resilient Research Peptides’ Retatrutide (10 mg) is supplied exclusively for laboratory research purposes.
Retatrutide is provided strictly for non-clinical, in-vitro, and experimental research applications. No medical, physiological, therapeutic, or diagnostic claims are made or implied.
In controlled laboratory settings, Retatrutide has been investigated for its interaction with multiple peptide receptor pathways under experimental conditions. Research remains limited to laboratory environments.
Resilient Research Peptides supplies this compound solely as a research material and does not provide guidance regarding clinical use, dosing, administration, or application.
Product Specifications
Compound: Retatrutide
Quantity: 10 mg per vial
Form: Lyophilized powder
Purity: ≥98%
Testing: Independently verified
Intended Use: Laboratory research only
Certificate of Analysis available upon request.
Storage & Handling
Store according to established laboratory reagent handling procedures.
For use in properly equipped research facilities only.
⚠️ Research Use Only (RUO)
Not for human or veterinary use.
Not intended for diagnosis, treatment, mitigation, or prevention of disease.
No instructions for dosing, administration, or experimental application are provided.
SLU-PP-332 is a synthetic compound currently being investigated in laboratory models for its interaction with metabolic receptor pathways.
Strictly for research purposes only. Not for human or animal consumption.
🧬 OVERVIEW
SLU-PP-332 is studied in preclinical settings for its interaction with receptor pathways associated with metabolic signaling. Laboratory research has focused on receptor binding activity, transcriptional response, and pathway modulation under controlled experimental conditions.
⚗️ RESEARCH APPLICATIONS
Nuclear receptor interaction studies
Metabolic pathway signaling research
Gene transcription analysis
Ligand-receptor binding studies
⚠️ DISCLAIMER BLOCK
This product is intended exclusively for laboratory research.
Not for ingestion or injection
Not for medical or therapeutic use
Use restricted to controlled research environments
